Suppr超能文献

垂体上动脉动脉瘤经血管内治疗后复发率最低。

Superior hypophyseal artery aneurysms have the lowest recurrence rate with endovascular therapy.

机构信息

Department of Neurosurgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, PA 19107, USA.

出版信息

AJNR Am J Neuroradiol. 2012 Sep;33(8):1502-6. doi: 10.3174/ajnr.A3004. Epub 2012 Mar 8.

Abstract

BACKGROUND AND PURPOSE

Given the challenges posed by surgical clipping, endovascular techniques have been increasingly used to treat SHA aneurysms. The purpose of this study was to assess the safety and efficacy of endovascular techniques in the treatment of SHA aneurysms.

MATERIALS AND METHODS

Medical charts and initial and follow-up angiograms were reviewed retrospectively for all patients treated with endovascular procedures at our institution between January 2006 and February 2011.

RESULTS

We identified 87 patients with SHA aneurysms who were treated with endovascular techniques. Of these patients, 79 were women and only 8 were men (90.8% female predominance). Thirty-five patients were treated with coil embolization; 45, with stent-assisted coiling; 4, with balloon-assisted coil embolization; and 3, with a flow-diversion technique. Minor complications occurred in 2 patients (2.2%). None of the patients had a major complication. The mortality and permanent morbidity rates related to the procedure were 0%. Imaging follow-up was available for 89.4% of patients (DSA in 65, MRA in 11 patients) at a mean time point of 10.4 months (range, 6-60 months). Of the 76 patients with available follow-up, 3 patients had a recurrence (3.9%) and only 1 required further intervention (1.3%). Stent-assisted coiling was associated with lower recurrence rates than simple coil embolization.

CONCLUSIONS

SHA aneurysms have the lowest recurrence rate with endovascular treatment compared with aneurysms in other locations by using historical data. Because of its safety and efficacy, endovascular therapy should be considered the procedure of choice for the treatment of SHA aneurysms.

摘要

背景与目的

鉴于手术夹闭带来的挑战,血管内技术已越来越多地用于治疗前交通动脉(anterior communicating artery,SHA)动脉瘤。本研究旨在评估血管内技术治疗 SHA 动脉瘤的安全性和有效性。

材料与方法

回顾性分析 2006 年 1 月至 2011 年 2 月期间在我院接受血管内治疗的所有 SHA 动脉瘤患者的病历和初始及随访血管造影资料。

结果

共纳入 87 例 SHA 动脉瘤患者,其中 79 例为女性,仅 8 例为男性(90.8%为女性)。35 例患者接受了线圈栓塞治疗;45 例患者接受了支架辅助线圈栓塞治疗;4 例患者接受了球囊辅助线圈栓塞治疗;3 例患者接受了血流导向技术治疗。2 例(2.2%)患者出现轻微并发症。无严重并发症发生。与该操作相关的死亡率和永久性并发症发生率均为 0%。89.4%的患者(65 例行 DSA,11 例行 MRA)获得了影像学随访,平均随访时间为 10.4 个月(范围:6-60 个月)。在 76 例有随访资料的患者中,3 例(3.9%)复发,仅 1 例(1.3%)需要进一步介入治疗。支架辅助线圈栓塞治疗的复发率低于单纯线圈栓塞治疗。

结论

本研究采用历史数据比较,发现与其他部位的动脉瘤相比,血管内治疗 SHA 动脉瘤的复发率最低。鉴于其安全性和有效性,血管内治疗应被视为治疗 SHA 动脉瘤的首选方法。

相似文献

7

本文引用的文献

1
Paraclinoid carotid aneurysms.鞍旁颈动脉动脉瘤。
J Clin Neurosci. 2011 Jan;18(1):13-22. doi: 10.1016/j.jocn.2010.06.020. Epub 2010 Dec 3.
2
Endovascular management of intracranial aneurysms.颅内动脉瘤的血管内治疗。
Neurosurg Clin N Am. 2009 Oct;20(4):383-98. doi: 10.1016/j.nec.2009.07.003.
10
Endovascular treatment of paraclinoid aneurysms: experience with 73 patients.床突旁动脉瘤的血管内治疗:73例患者的经验
Neurosurgery. 2003 Jul;53(1):14-23; discussion 24. doi: 10.1227/01.neu.0000068789.08955.1c.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验